The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, ...

The company has received approval to validate and define the feature in a study that is scheduled to start this year.

In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a ...

The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall ...

Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral ...

Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.